Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022)
Neurocrine Biosciences' (NBIX) quarterly Other Non Operating Income came in at -$70.0 million in Q2 2022, down 280.43% quarter-over-quarter from -$18.4 million in Q4 2020.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022) Analysis & Trends
Neurocrine Biosciences (NBIX) has reported Other Non Operating Income for 8 consecutive years, with -$70.0 million the latest figure, recorded in Q2 2022.
- For the quarter ending Q2 2022, Other Non Operating Income changed N/A year-over-year to -$70.0 million; the trailing twelve-month figure through Jun 2023 stood at -$70.0 million (changed 0.0% YoY), and the FY2022 full-year result was -$70.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$70.0 million in Q2 2022 per NBIX's latest filing, from -$18.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$18.4 million in Q4 2020 and bottomed at -$70.0 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -70.00 Mn |
| Dec 31, 2020 | -18.40 Mn |
| Dec 31, 2015 | 20,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Dec 31, 2013 | 15,000.00 |
| Sep 30, 2013 | -5,000.00 |
| Jun 30, 2013 | 4,000.00 |
| Mar 31, 2013 | 2,000.00 |
| Dec 31, 2012 | 5,000.00 |
| Sep 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 5,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Sep 30, 2011 | 18,000.00 |
| Jun 30, 2011 | 5,000.00 |
| Mar 31, 2011 | 8,000.00 |
| Dec 31, 2010 | 996,000.00 |
| Jun 30, 2010 | 35,000.00 |